| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 瓜子金皂苷己; Polygalasaponin F | CFN90171 | 882664-74-6 | C53H86O23 = 1091.3 | 20mg | QQ客服：2159513211 |
| Sebiferenic acid; Sebiferenic acid | CFN97523 | 94390-09-7 | C30H48O4 = 472.7 | 5mg | QQ客服：1413575084 |
| 百两金素A; Ardisiacrispin A | CFN90177 | 23643-61-0 | C52H84O22 = 1061.21 | 5mg | QQ客服：215959384 |
| 白头翁皂苷A3; Anemoside A3 | CFN90182 | 129724-84-1 | C41H66O12 = 750.96 | 20mg | QQ客服：3257982914 |
| 常春藤苷C； 常春藤皂苷C; Hederacoside C | CFN90183 | 14216-03-6 | C59H96O26 = 1221.38 | 20mg | QQ客服：215959384 |
| 9(11),12-齐墩果二烯-3beta-醇; 9(11),12-Oleanadien-3-ol | CFN97528 | 94530-87-7 | C30H48O = 424.7 | 5mg | QQ客服：2056216494 |
| 常春藤苷D； 常春藤皂苷D; Hederacoside D | CFN90184 | 760961-03-3 | C53H86O22 = 1074.56 | 20mg | QQ客服：1413575084 |
| 番石榴二醛; Guajadial | CFN97539 | 959860-49-2 | C30H34O5 = 474.6 | 5mg | QQ客服：1457312923 |
| 七叶胆苷XVI; Gypenoside XVII | CFN90193 | 80321-69-3 | C48H82O18 = 947.16 | 20mg | QQ客服：215959384 |
| 泽泻醇 A 24-醋酸酯; Alisol A 24-acetate | CFN90198 | 18674-16-3 | C32H52O6 = 532.75 | 20mg | QQ客服：2056216494 |
| 泽泻醇 C-23-醋酸酯; Alisol C monoacetate | CFN90199 | 26575-93-9 | C32H48O6 = 528.73 | 20mg | QQ客服：2056216494 |
| 葫芦素D; Cucurbitacin D | CFN90209 | 3877-86-9 | C30H44O7 = 516.67 | 10mg | QQ客服：1413575084 |
| 凤仙萜四醇苷M; Hosenkoside M | CFN97548 | 161016-51-9 | C53H90O24 = 1111.3 | 5mg | QQ客服：1457312923 |
| (3beta,22E)-9,19-环羊毛甾-22-烯-3,25-二醇; Cycloart-22-ene-3,25-diol | CFN97555 | 97456-49-0 | C30H50O2 = 442.7 | 5mg | QQ客服：2159513211 |
| beta-乳香酸; Beta-boswellic acid | CFN90221 | 631-69-6 | C30H48O3 = 456.70 | 20mg | QQ客服：3257982914 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)